英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
AZ6102
|
1645286-75-4 |
REL-2-[4-[6-[(3R,5S)-3,5-二甲基-1-哌嗪基]-4-甲基-3-吡啶基]苯基]-3,7-二氢-7-甲基-4H-吡咯并[2,3-D]嘧啶-4-酮
|
REL-2-[4-[6-[(3R,5S)-3,5-二甲基-1-哌嗪基]-4-甲基-3-吡啶基]苯基]-3,7-二氢-7-甲基-4H-吡咯并[2,3-D]嘧啶-4-酮;CS-2332;AZ-6102;AZ6102;AZ 6102
|
C25H28N6O |
428.52942 | |
CP-533536
|
223488-57-1 |
2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸
|
EVATANEPAG;CP-533536;CP 533536;CS-2325;CP-533536;CP 533536;CP533536;2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸
|
C25H28N2O5S |
468.56 | |
RS-1
|
312756-74-4 |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
|
大鼠皮肤成纤维样细胞;4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺
|
C20H16Br2N2O3S |
524.22564 | |
GSK J1
|
1373422-53-7 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸;GSK J1(锂盐);CS-2305
|
C22H23N5O2 |
389.45032 | 200-258-5 |
FPS-ZM1
|
945714-67-0 |
N-BENZYL-4-CHLORO-N-CYCLOHEXYLBENZAMIDE
|
CS-2304;FPS-ZM1;4-氯-N-环己基-N-(苯基甲基)苯甲酰胺
|
C20H22ClNO |
327.84778 | |
DB07268
|
929007-72-7 |
2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺
|
CS-2303;2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺;DB07268;DB 07268;DB-07268;2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺 500MG
|
C17H15N5O2 |
321.3333 | |
MK-4827
|
1038915-60-4 |
尼拉帕尼
|
MK 4827;MK-4827;MK4827;-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺;(S)-2-(4-(哌啶-3-基)苯基)-2H-吲唑-7-羧酰胺;尼拉帕布;尼拉帕尼(碱);(S)-2-((哌啶-3-基)苯基)-吲唑-7-甲酰胺;2-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺;尼拉帕尼
|
C19H20N4O |
320.3883 | |
MK-1439
|
1338225-97-0 |
MK-1439
|
MK-1439;3-chloro-5-((1-((4-Methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)Methyl)-2-oxo-4-(trifluoroMethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile;3-Chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]benzonitrile;Doravirine / MK-1439;Doravirine;MK-1439(Doravirine);Benzonitrile, 3-chloro-5-[[1-[(4,5-dihydro-4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-1,2-dihydro-2-oxo-4-(trifluoromethyl)-3-pyridinyl]oxy]-;3-chloro-5-[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile
|
C17H11ClF3N5O3 |
||
oritavancin
|
171099-57-3 |
奥利万星
|
奥利万星磷酸盐;ORITAVANCIN奥利万星;CS-2274;盐酸阿拉格雷;LY333328;LY-333328;LY 333329;ORITAVANCIN
|
C86H97Cl3N10O26 |
1793.12 | |
anidulafungin
|
166663-25-8 |
阿尼芬净
|
阿尼芬净;阿尼分净;CS-2273;阿尼杜拉芬金杂质;ANIDULAFUNGIN阿尼芬净;安多拉芬净
|
C58H73N7O17 |
1140.24 | 658-060-4 |
AC710
|
1351522-04-7 |
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺
|
N-[4-[[[[5-(叔丁基)-3-异恶唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺;AC 710;AC-710;AC710;AC 710;AC-710;CS-2269
|
C31H42N6O4 |
562.70298 | |
JI-101
|
900573-88-8 |
1-[1-[(2-氨基吡啶-4-基)甲基]-1H-吲哚-4-基]-3-(5-溴-2-甲氧基苯基)脲
|
JI101;JI 101;1-[1-[(2-氨基吡啶-4-基)甲基]-1H-吲哚-4-基]-3-(5-溴-2-甲氧基苯基)脲;CS-2268
|
C22H20BrN5O2 |
466.3305 | |
RO8994
|
1309684-94-3 |
RO 8994
|
RO8994;RO 8994;CS-2264
|
C31H31Cl2FN4O4 |
613.511 | |
Dalbavancin
|
171500-79-1 |
达巴万星
|
道古霉素;道古霉素盐酸盐;道古霉素盐酸盐多少钱;MDL-63397;BI-398;道古霉素;达巴万星;达巴霉素;道古霉素,达巴万星,达巴霉素
|
C88H100Cl2N10O28 |
1816.71 | |
NS-398
|
123653-11-2 |
抑制剂
|
N-[2-(环己氧基)-4-硝基苯基]甲烷磺酰胺;抑制剂;N-[2-(环己氧基)-4-硝基苯基]甲基磺酰胺;NS-398抑制剂;N-[2-(环己氧基)-4-硝基苯基]甲烷磺酰胺;NS-398(COX-2抑制剂);N-(2-(环己基氧基)-4-硝基苯基)甲磺酰胺;CS-2231;NS 398;NS398;N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANE SULFONAMIDE
|
C13H18N2O5S |
314.36 | |
LHW090-A7
|
1308256-94-1 |
(ALPHAS)-3'-氯-ALPHA-[[(1S)-2-乙氧基-1-甲基-2-氧代乙基]氨基][1,1'-联苯]-4-丙酸
|
(ALPHAS)-3'-氯-ALPHA-[[(1S)-2-乙氧基-1-甲基-2-氧代乙基]氨基][1,1'-联苯]-4-丙酸;CS-2208;(ALPHAS)-3'-氯-ALPHA-[[(1S)-2-乙氧基-1-甲基-2-氧代乙基]氨基][1,1'-联苯]-4-丙酸
|
C20H22ClNO4 |
375.84598 | |
Velpatasvir
|
1377049-84-7 |
维帕他韦
|
CS-2204;GS 5816;维帕他韦;GS-5816(韦帕它韦);维帕他韦中间体A13;维帕他韦GS5816;韦帕他韦;维帕他韦()
|
C49H54N8O8 |
883.00186 | 1592732-453-0 |
INK1117
|
1268454-23-4 |
[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮
|
CS-2200;[6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮;INK1117;INK-1117;INK 1117;MLN1117;MLN 1117;MLN-1117;TAK-117;TAK 117;TAK117;(6-(2-氨基苯并[D]恶唑-5-基)咪唑并[1,2-A]吡啶-3-基)-4-吗啉基甲酮
|
C19H17N5O3 |
363.36998 | |
GSK744 (S/GSK1265744)
|
1051375-10-0 |
Cabotegravir (GSK744, GSK1265744)
|
(3S,11AR)-N-[(2,4-二氟苯基)甲基]-2,3,5,7,11,11A-六氢-6-羟基-3-甲基-5,7-二氧代恶唑并[3,2-A]吡啶并[1,2-D]吡嗪-8-甲酰胺;卡博特韦自由酸
|
C19H17F2N3O5 |
405.3521864 | |
SGC707
|
1687736-54-4 |
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
|
CS-2192;SGC 707;SGC707;N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲;1-(异喹啉-6-基)-3-(2-氧代-2-(吡咯烷-1-基)乙基)脲
|
C16H18N4O2 |
298.33972 |